Ceftiofur for Koi Fish: Uses, Dosing & Veterinary Considerations

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Ceftiofur is a prescription third-generation cephalosporin antibiotic. In fish medicine, it may be considered by your vet for certain suspected or confirmed bacterial infections, especially when a koi has ulcers, tissue infection, or is too sick to reliably eat medicated food. It is not labeled specifically for koi, so its use in ornamental fish is typically extra-label and veterinarian-directed.

Ceftiofur works by interfering with bacterial cell wall formation. It has activity against a range of gram-negative and some gram-positive bacteria, and older laboratory work found it was highly active in vitro against Aeromonas hydrophila and Aeromonas sobria isolated from ornamental fish. That matters because Aeromonas species are common players in koi ulcer disease, but culture and sensitivity testing still matters because not every ulcer is caused by the same organism.

For koi, ceftiofur is usually discussed as an injectable medication, not a pond-wide treatment. Merck notes that medicated food is often the most common route for pet fish, but injection is the most accurate way to control how much antimicrobial a fish actually receives. In a sick koi that has stopped eating, that can make a meaningful difference.

Because fish medicine depends heavily on water temperature, handling stress, body condition, and water quality, ceftiofur should be viewed as one part of a treatment plan, not a stand-alone fix. Your vet may pair antibiotic decisions with sedation, wound care, water testing, parasite checks, and quarantine recommendations.

In koi practice, ceftiofur may be considered for bacterial skin and soft tissue infections, especially ulcerative disease, cellulitis, or deeper infections where your vet suspects susceptible bacteria. It may also come up when a koi has systemic illness signs such as lethargy, loss of appetite, fin base redness, swelling, or worsening ulcers that suggest bacteria may be moving beyond the skin.

One reason vets may consider ceftiofur is its documented activity against ornamental fish Aeromonas isolates in laboratory testing. That said, koi ulcers are often a syndrome rather than a single diagnosis. Parasites, poor water quality, trauma, spawning injury, and temperature swings can all set the stage for secondary bacterial infection. If those drivers are not addressed, antibiotics alone may not work well.

Your vet may be more likely to use ceftiofur when a koi is not eating, when medicated feed is unlikely to deliver a reliable dose, or when the fish is valuable enough that precise injection-based treatment is worth the handling and sedation involved. In some cases, your vet may recommend a different antibiotic instead, based on culture results, prior treatment history, or concern for tissue irritation.

Ceftiofur is not a routine first step for every red spot or sore. Mild superficial lesions may be managed with improved water quality, quarantine, parasite control, and local wound care, while severe or rapidly progressive disease may need culture, imaging, or more intensive support. The right option depends on the fish, the pond, and what your vet finds on exam.

There is no single universal ceftiofur dose for all koi cases, and pet parents should not dose this medication without veterinary guidance. Published fish data show that ceftiofur sodium has been studied in grass carp at 8 mg/kg by several routes, with the authors concluding that this dose had potential as a useful therapeutic level. In koi, an extended-release ceftiofur crystalline-free acid formulation has also been studied, and 60 mg/kg IM produced serum concentrations above a target level for roughly 0.4 to 2.5 weeks in 3 of 4 fish. Those are research findings, not a home-use dosing chart.

In real practice, your vet chooses the dose, route, and interval based on the formulation used. Ceftiofur sodium, ceftiofur hydrochloride, and ceftiofur crystalline-free acid are not interchangeable on a mg-for-mg schedule. Water temperature also matters because fish metabolism slows in colder water, which can change how long a drug stays active.

For koi, injectable antibiotics are often given intramuscularly or intracoelomically, usually after sedation to reduce stress and improve accuracy. Merck notes that injection is the most effective way to control the amount of antimicrobial delivered to a fish, but repeated handling can still be hard on a sick koi. Your vet may decide that fewer injections with a longer-acting product make sense, or may avoid ceftiofur altogether if another drug is a better fit.

Never estimate a koi's weight by eye if your vet is prescribing an injectable antibiotic. Small math errors can become large dosing errors in fish. Your vet may weigh the koi in a damp sling or tub, calculate the exact volume to draw up, and set a recheck plan based on appetite, ulcer healing, swimming behavior, and water quality trends.

Side effects reported or reasonably expected with ceftiofur in koi and other fish include injection-site irritation, swelling, tissue damage, stress from handling, and appetite suppression after treatment or sedation. In fish, the medication itself is only part of the risk picture. Capture, restraint, anesthesia, and repeated netting can all worsen recovery if the koi is already weak.

Research in grass carp found that a very high intramuscular dose caused posterior kidney lesions at 10 times the studied dose, while the recommended 8 mg/kg dose appeared better tolerated. That does not mean every koi will react the same way, but it is one reason your vet will be careful with formulation choice, dose calculation, and treatment frequency.

Call your vet promptly if your koi shows worsening buoyancy problems, rolling, severe lethargy, new hemorrhage, rapid gill movement, refusal to recover after sedation, or worsening ulcer depth after treatment. Those signs may reflect disease progression, water quality trouble, injection trauma, or a poor response to the medication plan.

If your koi is part of a mixed pond, remember that the sick fish may need quarantine and lower-stress monitoring even if the medication is injectable. That helps your vet tell whether the fish is improving and reduces the chance that pond mates, parasites, or unstable water conditions will keep setting the infection back.

Published koi-specific drug interaction data for ceftiofur are limited, so your vet will usually make decisions based on fish medicine principles plus cephalosporin pharmacology. The biggest practical issue is not always a classic drug-drug interaction. It is the combined stress of multiple treatments at once: sedation, injectable antibiotics, salt changes, topical ulcer care, parasite medications, and water chemistry shifts can all affect recovery.

Your vet may use extra caution if ceftiofur is being combined with other potentially nephrotoxic or tissue-irritating medications, especially in a dehydrated or systemically ill fish. Merck specifically notes nephrotoxicity concerns with injectable amikacin in fish, so stacking injectable drugs without a clear plan can increase risk. If your koi recently received another antibiotic, tell your vet exactly what it was, how it was given, and for how long.

It is also important to discuss any pond-wide treatments already in use, including salt, formalin-based products, potassium permanganate, medicated food, or parasite treatments. These may not directly inactivate ceftiofur, but they can change stress level, gill function, appetite, or healing. That affects whether an antibiotic plan is likely to succeed.

Finally, ceftiofur has important regulatory and food-safety considerations. If there is any chance the koi could enter the human food chain, your vet needs to know before prescribing. Ornamental fish are treated differently from food fish in practice, and residue concerns can change what medications are appropriate.